1. Japan Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 92
Price: Single User License – US$2500
Japan Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Japan Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Japan Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Japan Diabetes Care
Devicesmarket.
- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S,
ARKRAY, Inc., Eli Lilly and Company, Sanofi and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Japan Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197483-japan-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Japan 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 11
3.3 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2011 12
3.4 Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 13
3.5 Diabetes Care Devices, Japan, Company Share (2010-2011) 20
4 Glucose Monitoring In Japan 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Japan, Revenue Mix ($m), 2011 23
4.3 Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 24
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 25
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 29
4.5 Glucose Monitoring Overall Volume (2004-2018) 33
4.5.1 Blood Glucose Meters, Volume (2004-2018) 37
4.6 Glucose Monitoring Average Price (2004-2018) 39
4.7 Glucose Monitoring Distribution Share (2010-2011) 40
4.8 Glucose Monitoring, Japan, Company Share (2010-2011) 41
5 Insulin Delivery In Japan 43
5.1 Insulin Delivery, Market Segmentation 43
5.2 Insulin Delivery Market, Japan, Revenue Mix ($m), 2011 44

3. 5.3 Insulin Delivery Market, Japan, Segment Contribution (%), 2011 45
5.4 Insulin Delivery Overall Revenue, (2004-2018) 46
5.4.1 Insulin Pens, Revenue (2004-2018) 50
5.4.2 Insulin Pumps, Revenue (2004-2018) 54
5.5 Insulin Delivery Overall Volume (2004-2018) 56
5.5.1 Insulin Pens, Volume (2004-2018) 60
5.5.2 Insulin Pumps, Volume (2004-2018) 64
5.6 Insulin Delivery Average Price (2004-2018) 66
5.7 Insulin Delivery Distribution Share (2010-2011) 67
5.8 Insulin Delivery, Japan, Company Share (2010-2011) 68
6 Overview of Key Companies in Japan Diabetes Care Devices Market 70
6.1 LifeScan, Inc. 70
6.1.1 Company Overview 70
6.1.2 Share in the Japan Diabetes Care Devices Market 70
6.2 F. Hoffmann-La Roche Ltd. 71
6.2.1 Company Overview 71
6.2.2 Share in the Japan Diabetes Care Devices Market 71
6.3 Novo Nordisk A/S 72
6.3.1 Company Overview 72
6.3.2 Share in the Japan Diabetes Care Devices Market 72
6.4 ARKRAY, Inc. 73
6.4.1 Company Overview 73
6.4.2 Share in the Japan Diabetes Care Devices Market 73
6.5 Eli Lilly and Company 74
6.5.1 Company Overview 74
6.5.2 Share in the Japan Diabetes Care Devices Market 74
6.6 Sanofi 75
6.6.1 Company Overview 75
6.6.2 Share in the Japan Diabetes Care Devices Market 75
6.7 Terumo Corporation 76
6.7.1 Company Overview 76
6.8 Abbott Laboratories 76
6.8.1 Company Overview 76
6.9 Bayer HealthCare AG 77
6.9.1 Company Overview 77
6.10 Terumo Corporation 77
6.10.1 Company Overview 77
6.11 Medtronic, Inc. 78
6.11.1 Company Overview 78
6.12 Apex Biotechnology Corp. 78
6.12.1 Company Overview 78
7 Diabetes Care Devices Market Pipeline Products 79

4. 8 Financial Deals Landscape 82
8.1 Partnerships 82
8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 82
9 Recent Developments 83
9.1 Strategy And Business Planning 83
9.1.1 Aug 09, 2012: Takeda Establishes Development Center In China 83
9.1.2 Mar 27, 2012: Terumo Establishes New Holding Company In Singapore 83
9.1.3 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 83
9.2 Research And Development 84
9.2.1 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug
Research 84
9.3 Legal and Regulatory 85
9.3.1 Aug 01, 2012: Terumo Files Lawsuit For Compensation Of Damages Against Olympus 85
9.3.2 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 85
9.3.3 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In
Dispute With Takeda 85
10 Appendix 86
10.1 Definitions of Markets Covered in the Report 87
10.1.1 Diabetes Care Devices 87
10.2 Research Methodology 89
10.3 Secondary Research 89
10.4 Primary Research 90
10.5 Models 90
10.6 Forecasts 91
10.7 Expert Panels 91
10.8 GlobalData Consulting 91
10.9 Currency Conversion 91
10.10 Contact Us 91
10.11 Disclaimer 92
1.1 List of Tables
Table 1: Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 11
Table 2: Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 13
Table 3: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2004-2018 15
Table 4: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 17
Table 5: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 19
Table 6: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-
2011 21
Table 7: Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 24
Table 8: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-

5. 2011 26
Table 9: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-
2018 28
Table 10: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 30
Table 11: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 32
Table 12: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2004-2011 34
Table 13: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2011-2018 36
Table 14: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 37
Table 15: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018
38
Table 16: Glucose Monitoring, Japan, Average Price ($), Historic, 2004-2011 39
Table 17: Glucose Monitoring, Japan, Average Price ($), Forecast, 2011-2018 39
Table 18: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 40
Table 19: Glucose Monitoring, Japan, Company Share by Revenue ($m), USD Constant, 2010-
2011 42
Table 20: Insulin Delivery Market, Japan, Segment Contribution (%), 2011 45
Table 21: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011
47
Table 22: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-
2018 49
Table 23: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 51
Table 24: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 53
Table 25: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,
Historic, 2004-2011 54
Table 26: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,
Forecast, 2011-2018 55
Table 27: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2004-2011 57
Table 28: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2011-2018 59
Table 29: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 61
Table 30: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63
Table 31: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2004-2011
64
Table 32: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2011-2018
65
Table 33: Insulin Delivery, Japan, Average Price ($), Historic, 2004-2011 66
Table 34: Insulin Delivery, Japan, Average Price ($), Forecast, 2011-2018 66
Table 35: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011

6. 67
Table 36: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
69
Table 37: Diabetes Care Devices Market Pipeline Products 79
Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 82
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2011 12
Figure 4: Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 13
Figure 5: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2004-2018 14
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 18
Figure 8: Diabetes Care Devices, Japan, Company Share (%), 2011 20
Figure 9: Glucose Monitoring, Market Segmentation 22
Figure 10: Glucose Monitoring Market, Japan, Revenue Mix ($m), 2011 23
Figure 11: Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 24
Figure 12: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-
2011 25
Figure 13: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Forecast,
2011-2018 27
Figure 14: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 29
Figure 15: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 31
Figure 16: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2004-2011 33
Figure 17: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2011-2018 35
Figure 18: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 37
Figure 19: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018
38
Figure 20: Glucose Monitoring, Japan, Company Share (%), 2011 41
Figure 21: Insulin Delivery, Market Segmentation 43
Figure 22: Insulin Delivery Market, Japan, Revenue Mix ($m), 2011 44
Figure 23: Insulin Delivery Market, Japan, Segment Contribution (%), 2011 45
Figure 24: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-
2011 46
Figure 25: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-
2018 48
Figure 26: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-

7. 2011 50
Figure 27: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 52
Figure 28: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,
Historic, 2004-2011 54
Figure 29: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,
Forecast, 2011-2018 55
Figure 30: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2004-2011 56
Figure 31: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2011-2018 58
Figure 32: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 60
Figure 33: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62
Figure 34: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2004-2011
64
Figure 35: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2011-2018
65
Figure 36: Insulin Delivery, Japan, Company Share (%), 2011 68
Figure 37: LifeScan, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2011 70
Figure 38: F. Hoffmann-La Roche Ltd., Company Share (%),Japan Diabetes Care Devices Market,
2011 71
Figure 39: Novo Nordisk A/S, Company Share (%),Japan Diabetes Care Devices Market, 2011 72
Figure 40: ARKRAY, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2011 73
Figure 41: Eli Lilly and Company, Company Share (%),Japan Diabetes Care Devices Market,
2011 74
Figure 42: Sanof, Company Share (%),Japan Diabetes Care Devices Market, 2011 75
Contact: sales@reportsandreports.com for more information.